George Tziras
Fortuna: 452 490 $ al 31/08/2026
Fortuna: 452 490 $ al 31/08/2026
George Tziras is currently Chief Executive Officer & Director at Small Pharma, Inc. since 2022, Non-Executive Director at Cybin UK Ltd. since 2015, and Chief Business Officer at Cybin, Inc. starting in 2025.
Formerly, Mr. Tziras was Chief Business Officer & Director at Unilock Capital Corp.
Education includes undergraduate studies at the University of Oxford and graduate studies at The Paul H.
Nitze School of Advanced International Studies.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CYBIN, INC. 0,06 % | 02/09/2026 | 38.477 ( 0,06 % ) | 452 490 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SMALL PHARMA INC. | Director Ejecutivo | 20/07/2022 |
| CYBIN INC. | Contacto de Relaciones con Inversores | - |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Director/Miembro de la Junta | 01/01/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
| SMALL PHARMA INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.